Medscape reports national prescription data showing the pill reached that mark within two months of its January 2026 launch, with faster early uptake than injectable tirzepatide or semaglutide.
Recap by typeshit. Post by @medscape on Instagram.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
A shared excerpt points to TRIUMPH-2 results on how well retatrutide works and how safe it is. The snippet gives no numbers, so the full piece has the data.
Generic makers gain ground as another layer of semaglutide protection falls, per Life Sciences IP Review. Full story is behind a paywall.
Loading…